First-trimester screening for preeclampsia between 11 and 13 + 6 weeks of gestation and adverse perinatal outcomes
Journal of Ultrasound · 2025
DOI: 10.1007/s40477-025-01039-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ultrasound, 2025. Verfasst von Karine Mendonça Davi Rodrigues und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology and Obstetrics Service, Mario Palmério University Hospital - University of Uberaba (UNIUBE), Uberaba, MG, Brazil. Hauptthemen laut MEDLINE: Pre-Eclampsia, Pregnancy Trimester, First, Ultrasonography, Prenatal. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE: To evaluate the impact of first-trimester screening for preeclampsia (PE) and its association with adverse perinatal outcomes. METHODS: A retrospective cohort study was conducted in women with (Group I) or without (Group II) first-trimester screening for PE between 11 and 13 + 6 weeks using maternal characteristics, mean arterial pressure, and uterine artery Doppler. Women were classified as low and high risk using a cut-off value of 1:150 according to the Fetal Medicine Foundation guidelines. RESULTS: A total of 2442 pregnant women were analysed, 988 in Group I and 1434 in Group II, of whom 204 were at high risk and 1230 at low risk for PE. Group II had higher maternal age (28.0 vs. 26.0 years, p 37 weeks (2.9% vs. 0.5%, p = 0.005). Among women at high risk of PE, 61.3% (125/204) used aspirin (ASA) 100 mg by 37 weeks' gestation. The ASA use was associated with a lower risk of PE > 37 weeks' gestation (0.8% vs. 6.3%, p = 0.033). CONCLUSION: First-trimester screening for PE did not reduce the risk of preterm or term PE. First-trimester screening was associated with a lower risk of gestational hypertension and preterm PE. High risk pregnancies had a higher risk of preterm and term PE and of preterm and term delivery. ASA use was associated with lower risk of term PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecology and Obstetrics Service, Mario Palmério University Hospital - University of Uberaba (UNIUBE), Uberaba, MG, Brazil.
- Albert Einstein Israelite College of Health Sciences, Albert Einstein Israelite Hospital, São Paulo, SP, Brazil.
- Department of Radiology, Federal University of Triângulo Mineiro (UFTM), Uberaba, MG, Brazil.
- Sabin Diagnostic Medicine, Uberaba Unit, Uberaba, MG, Brazil.
- Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), Rua Belchior de Azevedo, 156 apto. 111 Torre Vitoria, São Paulo, SP, 05089-030, Brazil. araujojred@terra.com.br.
- Discipline of Woman Health, Municipal University of São Caetano do Sul (USCS), São Caetano do Sul, SP, Brazil. araujojred@terra.com.br.
Zitieren
APA
Rodrigues, K. M. D., de Lacerda Silva, M., Oliveira, B. C., Dos Santos, F. A. P., Callado, G. Y., de Sousa, L. R. M. F., Araujo Júnior, E., & Peixoto, A. B. (2025). First-trimester screening for preeclampsia between 11 and 13 + 6 weeks of gestation and adverse perinatal outcomes. Journal of Ultrasound. https://doi.org/10.1007/s40477-025-01039-2
Vancouver
Rodrigues KMD, de Lacerda Silva M, Oliveira BC, Dos Santos FAP, Callado GY, de Sousa LRMF, et al. First-trimester screening for preeclampsia between 11 and 13 + 6 weeks of gestation and adverse perinatal outcomes. Journal of Ultrasound. 2025. doi:10.1007/s40477-025-01039-2
BibTeX
@article{Rodrigues2025,
author = {Rodrigues, Karine Mendonça Davi and de Lacerda Silva, Marilia and Oliveira, Barbara Coppola and Dos Santos, Felipe Augusto Pereira and Callado, Gustavo Yano and de Sousa, Luis Ronan Marquez Ferreira and Araujo Júnior, Edward and Peixoto, Alberto Borges},
title = {First-trimester screening for preeclampsia between 11 and 13 + 6 weeks of gestation and adverse perinatal outcomes},
journal = {Journal of Ultrasound},
year = {2025},
doi = {10.1007/s40477-025-01039-2}
}
EUVIMED